about
Salivary biomarkers and proteomics: future diagnostic and clinical utilities.Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoformsTripping up Trp: Modification of protein tryptophan residues by reactive oxygen species, modes of detection, and biological consequencesMass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.Top-down analytical platforms for the characterization of the human salivary proteome.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.Recent developments and applications of capillary and microchip electrophoresis in proteomic and peptidomic analyses.Proteomics and the search for welfare and stress biomarkers in animal production in the one-health context.Proteomics applied to pediatric medicine: opportunities and challenges.Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study.Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.Top-down HPLC-ESI-MS characterization of rat gliadoralin A, a new member of the family of rat submandibular gland glutamine-rich proteins and potential substrate of transglutaminase.Putative salivary protein biomarkers for the diagnosis of oral lichen planus: a case-control study.Target identification reveals protein arginine methyltransferase 1 is a potential target of phenyl vinyl sulfone and its derivatives.Standardization of a protocol for shotgun proteomic analysis of saliva.
P2860
Q33777050-3080145A-C78C-40A8-87A3-454B0ADB8E88Q36072219-DAF0105C-6E14-486F-8274-60FD70E4D2B4Q36386406-504F2058-C62F-46EE-9EF0-B764F39CF387Q37566426-4037CCCD-2C37-42E6-97F4-77D0128936DDQ38191025-047E0E33-1BEF-4E13-8B64-1155B32919E5Q38552059-0A102DF7-9E57-4726-B26B-4BBC65F491BFQ38615219-2F1DBE6B-B67C-4D87-806F-0C42F6A4CDA8Q38756896-9108D0E4-6EB2-4B4A-BC2C-A0E8C18DFABAQ38833713-083DE05B-DAB7-4703-B8D4-F4664A108216Q39014494-CBEAF423-45AE-4BAD-BB97-E35452C47B3FQ44190698-C25C8897-4538-4005-87F8-F4B76306E841Q45783398-B3E98EAF-3269-431A-818E-782674407C6CQ51025729-8A28FCCD-0ABB-43E7-91C5-5C7D9EAB51B0Q55220663-CFC7EA7F-FBDF-4DC2-99B9-CF0E82B49DFAQ55248854-5D74B45A-D666-40A2-814E-85B22DDD28DAQ55339896-B712C581-4386-4ED3-9C18-6E3FC41CFF49
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Unraveling the different proteomic platforms.
@en
type
label
Unraveling the different proteomic platforms.
@en
prefLabel
Unraveling the different proteomic platforms.
@en
P2093
P2860
P356
P1476
Unraveling the different proteomic platforms.
@en
P2093
Andrea Urbani
Federica Vincenzoni
Massimo Castagnola
Tiziana Cabras
P2860
P304
P356
10.1002/JSSC.201200830
P577
2012-12-04T00:00:00Z